Annual SG&A
$9.62 M
-$730.20 K-7.06%
31 December 2023
Summary:
Hepion Pharmaceuticals annual selling, general & administrative expenses is currently $9.62 million, with the most recent change of -$730.20 thousand (-7.06%) on 31 December 2023. During the last 3 years, it has risen by +$1.47 million (+18.03%). HEPA annual SG&A is now -7.06% below its all-time high of $10.35 million, reached on 31 December 2022.HEPA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.70 M
+$328.30 K+24.01%
30 September 2024
Summary:
Hepion Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.70 million, with the most recent change of +$328.30 thousand (+24.01%) on 30 September 2024. Over the past year, it has dropped by -$450.50 thousand (-20.99%). HEPA quarterly SG&A is now -50.30% below its all-time high of $3.41 million, reached on 31 March 2023.HEPA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$919.79 M
-$22.70 M-2.53%
30 September 2024
Summary:
Hepion Pharmaceuticals TTM selling, general & administrative expenses is currently -$919.79 million, with the most recent change of -$22.70 million (-2.53%) on 30 September 2024. Over the past year, it has dropped by -$929.89 million (-9207.53%). HEPA TTM SG&A is now -285016.99% below its all-time high of $10.82 million, reached on 31 March 2023.HEPA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HEPA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -21.0% | -9207.5% |
| 3 y3 years | +18.0% | -37.6% | -9078.8% |
| 5 y5 years | +37.4% | +59.3% | -10000.0% |
HEPA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.1% | +18.0% | -50.3% | +24.0% | -100.3% | at low |
| 5 y | 5 years | -7.1% | +109.7% | -50.3% | +59.3% | -191.4% | at low |
| alltime | all time | -7.1% | +608.3% | -50.3% | +1637.2% | <-9999.0% | at low |
Hepion Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.70 M(+24.0%) | $7.48 M(-5.7%) |
| June 2024 | - | $1.37 M(-48.3%) | $7.93 M(-10.4%) |
| Mar 2024 | - | $2.64 M(+48.8%) | $8.85 M(-8.0%) |
| Dec 2023 | $9.62 M(-7.1%) | $1.78 M(-17.3%) | $9.62 M(-4.8%) |
| Sept 2023 | - | $2.15 M(-6.1%) | $10.10 M(-5.4%) |
| June 2023 | - | $2.29 M(-33.0%) | $10.68 M(-1.3%) |
| Mar 2023 | - | $3.41 M(+51.2%) | $10.82 M(+4.5%) |
| Dec 2022 | $10.35 M(+3.4%) | $2.26 M(-17.2%) | $10.35 M(+1.6%) |
| Sept 2022 | - | $2.73 M(+12.4%) | $10.18 M(+0.1%) |
| June 2022 | - | $2.43 M(-17.5%) | $10.17 M(-2.3%) |
| Mar 2022 | - | $2.94 M(+40.7%) | $10.42 M(+4.1%) |
| Dec 2021 | $10.01 M(+22.8%) | $2.09 M(-23.1%) | $10.01 M(-2.3%) |
| Sept 2021 | - | $2.72 M(+1.8%) | $10.24 M(+2.7%) |
| June 2021 | - | $2.67 M(+5.4%) | $9.98 M(+9.2%) |
| Mar 2021 | - | $2.53 M(+8.9%) | $9.13 M(+12.1%) |
| Dec 2020 | $8.15 M(+77.7%) | $2.33 M(-5.0%) | $8.15 M(+16.4%) |
| Sept 2020 | - | $2.45 M(+34.2%) | $7.00 M(+24.6%) |
| June 2020 | - | $1.83 M(+17.8%) | $5.62 M(+18.7%) |
| Mar 2020 | - | $1.55 M(+31.5%) | $4.73 M(+3.2%) |
| Dec 2019 | $4.59 M(-34.5%) | $1.18 M(+10.7%) | $4.59 M(-14.5%) |
| Sept 2019 | - | $1.06 M(+13.2%) | $5.36 M(-10.4%) |
| June 2019 | - | $939.90 K(-33.0%) | $5.98 M(-12.1%) |
| Mar 2019 | - | $1.40 M(-28.1%) | $6.80 M(-2.8%) |
| Dec 2018 | $7.00 M(+108.5%) | $1.95 M(+16.0%) | $7.00 M(+38.7%) |
| Sept 2018 | - | $1.68 M(-4.4%) | $5.05 M(-3.6%) |
| June 2018 | - | $1.76 M(+10.0%) | $5.24 M(-3.6%) |
| Mar 2018 | - | $1.60 M(-14.6%) | $5.43 M(-27.6%) |
| Dec 2017 | $3.36 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $1.87 M(-4.2%) | $7.50 M(+1.7%) |
| June 2017 | $7.37 M(+27.4%) | $1.96 M(-0.4%) | $7.37 M(+2.6%) |
| Mar 2017 | - | $1.96 M(+15.2%) | $7.19 M(+7.4%) |
| Dec 2016 | - | $1.70 M(-2.4%) | $6.69 M(+3.6%) |
| Sept 2016 | - | $1.75 M(-1.3%) | $6.45 M(+11.6%) |
| June 2016 | $5.79 M(+4.1%) | $1.77 M(+20.7%) | $5.79 M(-0.3%) |
| Mar 2016 | - | $1.47 M(-0.4%) | $5.80 M(-5.3%) |
| Dec 2015 | - | $1.47 M(+36.4%) | $6.13 M(+3.2%) |
| Sept 2015 | - | $1.08 M(-39.6%) | $5.94 M(+6.8%) |
| June 2015 | $5.56 M(+309.2%) | $1.79 M(-0.4%) | $5.56 M(+25.7%) |
| Mar 2015 | - | $1.79 M(+39.9%) | $4.42 M(+46.6%) |
| Dec 2014 | - | $1.28 M(+83.4%) | $3.02 M(+59.6%) |
| Sept 2014 | - | $698.50 K(+7.4%) | $1.89 M(+39.2%) |
| June 2014 | $1.36 M | $650.60 K(+68.3%) | $1.36 M(+92.0%) |
| Mar 2014 | - | $386.50 K(+150.8%) | $707.30 K(+120.5%) |
| Dec 2013 | - | $154.10 K(-7.6%) | $320.80 K(+92.4%) |
| Sept 2013 | - | $166.70 K(-90.6%) | $166.70 K(-93.3%) |
| Dec 2011 | - | $1.78 M(+573.4%) | $2.47 M(+181.7%) |
| Sept 2011 | - | $264.00 K(-4.1%) | $877.20 K(+20.0%) |
| June 2011 | - | $275.20 K(+78.4%) | $730.90 K(+17.7%) |
| Mar 2011 | - | $154.30 K(-16.0%) | $621.00 K(+6.5%) |
| Dec 2010 | - | $183.70 K(+56.1%) | $583.10 K(+14.7%) |
| Sept 2010 | - | $117.70 K(-28.8%) | $508.50 K(+4.1%) |
| June 2010 | - | $165.30 K(+42.0%) | $488.40 K(+13.5%) |
| Mar 2010 | - | $116.40 K(+6.7%) | $430.30 K(+3.9%) |
| Dec 2009 | - | $109.10 K(+11.8%) | $414.30 K(+35.7%) |
| Sept 2009 | - | $97.60 K(-9.0%) | $305.20 K(+47.0%) |
| June 2009 | - | $107.20 K(+6.8%) | $207.60 K(+106.8%) |
| Mar 2009 | - | $100.40 K | $100.40 K |
FAQ
- What is Hepion Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual SG&A year-on-year change?
- What is Hepion Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly SG&A year-on-year change?
- What is Hepion Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM SG&A year-on-year change?
What is Hepion Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of HEPA is $9.62 M
What is the all time high annual SG&A for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual selling, general & administrative expenses is $10.35 M
What is Hepion Pharmaceuticals annual SG&A year-on-year change?
Over the past year, HEPA annual selling, general & administrative expenses has changed by -$730.20 K (-7.06%)
What is Hepion Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of HEPA is $1.70 M
What is the all time high quarterly SG&A for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $3.41 M
What is Hepion Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, HEPA quarterly selling, general & administrative expenses has changed by -$450.50 K (-20.99%)
What is Hepion Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of HEPA is -$919.79 M
What is the all time high TTM SG&A for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM selling, general & administrative expenses is $10.82 M
What is Hepion Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, HEPA TTM selling, general & administrative expenses has changed by -$929.89 M (-9207.53%)